Sort
21,453 grants matching “tuberculosis”
Biochemistry of lysyl-tRNA synthetases
$312,625Michael Ibba · Ohio State University · R01 · FY2015 · GM
Biochemistry of lysyl-tRNA synthetases
$312,625Michael Ibba · Ohio State University · R01 · FY2012 · GM
Biochemistry of lysyl-tRNA synthetases
$312,625Michael Ibba · Ohio State University · R01 · FY2014 · GM
A novel whole ORFeome approach to identify CD8+ T cell responses to S. Typhi prot
$312,594Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2011 · AI
Innovative approaches for tuberculosis control in Brazil
$312,550Jose Roberto Lapa E Silva · Federal University Of Rio De Janeiro · U2R · FY2007 · TW
Molecular determinants of lung cancer in HIV infected and uninfected individuals in Uganda and Tanzania
$312,433Stanton L Gerson · Case Western Reserve University · U54 · FY2022 · CA
Molecular determinants of lung cancer in HIV infected and uninfected individuals in Uganda and Tanzania
$312,432Stanton L Gerson · Case Western Reserve University · U54 · FY2021 · CA
Pathogenesis of Infectious Diseases Training Program
$312,401Warren D. Johnson · Weill Medical Coll Of Cornell Univ · T32 · FY2006 · AI
Process and pathway based discovery of novel anti-TB drugs
$312,392David Alland · Rbhs-New Jersey Medical School · U19 · FY2018 · AI
TRANSMISSION OF PAUCIBACILLARY AND DRUG RESISTANT TB
$312,389Stanford University · U01 · FY2003 · AI
Virulence of the Opportunistic Pathogen Rhodococcis Equi
$312,330Mary Hondalus · University Of Georgia · R01 · FY2010 · AI
Replisome dynamics in M tuberculosis_linking persistence to genetic resistance
$312,295Digby Francis Warner · University Of Cape Town · U01 · FY2019 · HD
A Clustered Randomized Trial of DOTS Plus Active Case Finding
$312,266Solange Cavalcante · Johns Hopkins University · U19 · FY2008 · AI
Protection From Aminoglycoside Ototoxicity
$312,143Jochen Schacht · University Of Michigan At Ann Arbor · R01 · FY2012 · DC
Protection From Aminoglycoside Ototoxicity
$312,143Jochen Schacht · University Of Michigan At Ann Arbor · R01 · FY2011 · DC
Immune control of tuberculosis by IFN-gamma-inducible LRG-47
$312,141John D Macmicking · Yale University · R01 · FY2010 · AI
Granulysin: A Novel Cytolytic Molecule
$312,028Stanford University · R21 · FY2001 · AI
Alcohol and Reactivation TB
$311,992Carol M Mason · Lsu Health Sciences Center · R01 · FY2006 · AA
Role of LRG-47 (Irgm1) in EAE
$311,979Shi Du Yan · University Of Kansas Lawrence · R01 · FY2014 · NS
The Role of Glycolipids and CD1 in the Immunology of Leishmania Infection
$311,850Laurence U Buxbaum · University Of Pennsylvania · R01 · FY2010 · AI
Tandemly Repetitive Proteins in Mycoplasmas
$311,841Kevin F Dybvig · University Of Alabama At Birmingham · R01 · FY2008 · AI
Tandemly Repetitive Proteins in Mycoplasmas
$311,841Kevin F Dybvig · University Of Alabama At Birmingham · R01 · FY2009 · AI
HIV-associated Tuberculosis Training Program (HATTP)
$311,783Graeme Ayton Meintjes · University Of Cape Town · D43 · FY2018 · TW
Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment
$311,733Anthony Joseph Garcia-Prats · Stellenbosch University · R01 · FY2018 · HD
Metabolic determinants of Mtb virulence, vulnerability and variation
$311,641David Branch Moody · Brigham And Women'S Hospital · U19 · FY2025 · AI